Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Non-replicative phage particles delivering CRISPR-Cas9 to target major blaCTX-M variants. Local targets link to admitted publications; unresolved targets remain external evidence.
Antimicrobial Resistance: Implications and Costs
10.2147/idr.s234610 · 2019 · External reference
Extended-spectrum β-lactamases: a clinical update
10.1128/cmr.18.4.657-686.2005 · 2005 · External reference
Extended-spectrum β-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals
10.1016/j.vetmic.2014.01.017 · 2014 · External reference
ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli
10.1128/aac.49.1.447-450.2005 · 2005 · External reference
Growing group of extended-spectrum β-lactamases: the CTX-M enzymes
10.1128/aac.48.1.1-14.2004 · 2004 · External reference
Global epidemiology of CTX-M-type β-lactam resistance in human and animal
10.1016/j.cimid.2022.101815 · 2022 · External reference
Extended-spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options
10.1007/s40265-019-01180-3 · 2019 · External reference
CTX-M extended-spectrum β-lactamases among clinical isolates of Enterobacteriaceae in a Thai university hospital
2007 · External reference
The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand
10.1016/j.diagmicrobio.2007.02.005 · 2007 · External reference
Exploring the epidemiology of mcr genes, genetic context and plasmids in Enterobacteriaceae originating from pigs and humans on farms in Thailand
2023 · External reference
Multiple and high-Risk clones of extended-spectrum cephalosporin-resistant and blaNDM-5-harbouring uropathogenic Escherichia coli from cats and dogs in Thailand
10.3390/antibiotics10111374 · 2021 · External reference
Multilocus sequence typing and bla (ESBL) characterization of extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand
10.2147/idr.s209545 · 2019 · External reference
Extended spectrum β-lactamase-producing Escherichia coli among backyard poultry farms, farmers, and environments in Thailand
10.3382/ps/pez009 · 2019 · External reference
Amino acid substitutions causing inhibitor resistance in TEM β-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum β-lactamases
10.1093/jac/47.5.547 · 2001 · External reference
Unraveling the promise and limitations of CRISPR/Cas system in natural product research: Approaches and challenges.
10.1002/biot.202100507 · 2022 · External reference
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
10.1038/nbt.2507 · 2013 · External reference
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
10.1073/pnas.0800442106 · 2009 · External reference
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
10.1038/nbt.3043 · 2014 · External reference
Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy
10.1089/hum.2015.074 · 2015 · External reference
CRISPR/Cas9 in Genome Editing and Beyond
10.1146/annurev-biochem-060815-014607 · 2016 · External reference
CRISPR/Cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum β-lactamases
10.4014/jmb.1508.08080 · 2016 · External reference
Re-sensitization of Mycobacterium smegmatis to rifampicin using CRISPR interference demonstrates its utility for the study of non-essential drug resistance traits
10.3389/fmicb.2020.619427 · 2020 · External reference
Prevalence and characterization of plasmid-mediated blaESBL with their genetic environment in Escherichia coli and Klebsiella pneumoniae in patients with pneumonia
2012 · External reference
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
10.1073/pnas.1500107112 · 2015 · External reference
Phagemid vectors for phage display: properties, characteristics and construction
10.1016/j.jmb.2012.01.038 · 2012 · External reference
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
10.1038/nbt.3043 · 2014 · External reference
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
10.1038/nbt.3011 · 2014 · External reference
Preparation and Transformation of Competent E. coli Using Calcium Chloride
2006 · External reference
Membrane anchoring stabilizes and favors secretion of New Delhi metallo-β-lactamase
10.1038/nchembio.2083 · 2016 · External reference
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity
10.1126/science.1225829 · 2012 · External reference
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
10.1093/nar/gkz365 · 2019 · External reference
CRISPR guide RNA design guidelines for efficient genome editing
10.1007/978-1-0716-0712-1_19 · 2020 · External reference
10.1007/978-1-62703-764-8_9
10.1007/978-1-62703-764-8_9 · 2014 · External reference
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
10.1038/nbt.2508 · 2013 · External reference
Biotechnological mass production of DNA origami
10.1038/nature24650 · 2017 · External reference
Characterization of the cryptic plasmid pCC1 from Corynebacterium callunae and its use for vector construction
10.1016/j.plasmid.2003.09.002 · 2004 · External reference
Precipitation of filamentous bacteriophages for their selective recovery in primary purification
10.1002/btpr.705 · 2012 · External reference
Design and construction of targeted AAVP vectors for mammalian cell transduction
10.1038/nprot.2007.51 · 2007 · External reference
CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein
10.1371/journal.pone.0222588 · 2019 · External reference
Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system
10.1038/ncomms1937 · 2012 · External reference
Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation
10.1038/nbt.3026 · 2014 · External reference
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
10.1038/nbt.2889 · 2014 · External reference
Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system
10.1038/srep19675 · 2016 · External reference
Craspase is a CRISPR RNA-guided, RNA-activated protease
10.1126/science.add5064 · 2022 · External reference
Eliminating helper phage from phage display
10.1093/nar/gkl772 · 2006 · External reference